Evidence map›Paper›PMID 38580664›Full record

Articlenpj aging2024

Oxidative damage in the gastrocnemius predicts long-term survival in patients with peripheral artery disease.

Panagiotis Koutakis, Hernan Hernandez, Dimitrios Miserlis, Jonathan R Thompson, Evlampia Papoutsi, Constance J Mietus, Gleb Haynatzki, Julian K Kim, George P Casale, Iraklis I Pipinos

Open access · hybridAbstract read
In one paragraph

Article in npj aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Vascular adhesion molecule 1JVS-vascular science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Panagiotis KoutakisDepartment of Biology, Baylor University, Waco, TX, USA. Panagiotis_Koutakis@baylor.edu.ORCID http://orcid.org/0000-0002-8352-5667
Hernan HernandezDepartment of Surgery, University of Nebraska Medical Center, Omaha, NE, USA.
Dimitrios MiserlisDepartment of Surgery, University of Nebraska Medical Center, Omaha, NE, USA.
Jonathan R ThompsonDepartment of Surgery, University of Nebraska Medical Center, Omaha, NE, USA.
Evlampia PapoutsiDepartment of Biology, Baylor University, Waco, TX, USA.
Constance J MietusDepartment of Surgery, University of Nebraska Medical Center, Omaha, NE, USA.
Gleb HaynatzkiDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
Julian K KimDepartment of Biology, Baylor University, Waco, TX, USA.
George P CasaleDepartment of Surgery, University of Nebraska Medical Center, Omaha, NE, USA.
Iraklis I PipinosDepartment of Surgery, University of Nebraska Medical Center, Omaha, NE, USA. ipipinos@unmc.edu.
University of Nebraska Medical Center · USBaylor University · USNebraska Medical Center · USUniversity of Massachusetts Chan Medical School · US

Funding

Mitochondrial dysfunction, oxidative damage and inflammation in claudicationR01AG034995 · NIA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PIPINOS, IRAKLIS ILIAS · 2010 to 2014
$5.2M
Ramipril treatment of claudication: oxidative damage and muscle fibrosisR01AG049868 · NIA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI CASALE, GEORGE PASCO, PIPINOS, IRAKLIS ILIAS · 2015 to 2019
$4.7M
The Role of microRNA-210 in regulating oxidative stress in patients with peripheral artery diseaseR01AG064420 · NIA · UNIVERSITY OF WEST FLORIDA · PI KOUTAKIS, PANAGIOTIS · 2019 to 2023
$3.3M
MitoQ treatment of claudication: myofiber and micro-vessel pathologyR01AG077803 · NIA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Iraklis Ilias Pipinos · 2022 to 2026
$3.0M
NIA NIH HHS R01 AG034995NIA NIH HHS R01 AG049868NIA NIH HHS R01 AG064420NIA NIH HHS R01 AG077803
6 · The paper itself

Abstract

Patients with peripheral artery disease (PAD) have increased mortality rates and a myopathy in their affected legs which is characterized by increased oxidative damage, reduced antioxidant enzymatic activity and defective mitochondrial bioenergetics. This study evaluated the hypothesis that increased levels of oxidative damage in gastrocnemius biopsies from patients with PAD predict long-term mortality rates. Oxidative damage was quantified as carbonyl adducts in myofibers of the gastrocnemius of PAD patients. The oxidative stress data were grouped into tertiles and the 5-year, all-cause mortality for each tertile was determined by Kaplan-Meier curves and compared by the Modified Peto test. A Cox-regression model was used to control the effects of clinical characteristics. Results were adjusted for age, sex, race, body mass index, ankle-brachial index, smoking, physical activity, and comorbidities. Of the 240 study participants, 99 died during a mean follow up of 37.8 months. Patients in the highest tertile of oxidative damage demonstrated the highest 5-year mortality rate. The mortality hazard ratios (HR) from the Cox analysis were statistically significant for oxidative damage (lowest vs middle tertile; HR = 6.33; p = 0.0001 and lowest vs highest; HR = 8.37; p < 0.0001). Survival analysis of a contemporaneous population of PAD patients identifies abundance of carbonyl adducts in myofibers of their gastrocnemius as a predictor of mortality rate independently of ankle-brachial index, disease stage and other clinical and myopathy-related covariates.

Identifiers

PMID38580664
PMCPMC10997596
OpenAlexW4393991657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.